41
TITLE: Proteomics techniques for cystic fibrosis research
AUTHORS: Roxo Rosa, M ; Davezac, N; Bensalem, N; Majumder, M; Heda, GD; Simas, A; Penque, D ; Amaral, MD ; Lukacs, GL; Edelman, A;
PUBLISHED: 2004, SOURCE: Journal of Cystic Fibrosis, VOLUME: 3, ISSUE: SUPPL. 2
INDEXED IN: Scopus
42
TITLE: Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin
AUTHORS: Doucet, L; Mendes, F ; Montier, T; Delepine, P; Penque, D ; Ferec, C; Amaral, MD ;
PUBLISHED: 2003, SOURCE: JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, VOLUME: 51, ISSUE: 9
INDEXED IN: Scopus WOS
IN MY: ORCID
43
TITLE: Transcript analysis of the cystic fibrosis splicing mutation 1525-1G > A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers
AUTHORS: Ramalho, AS ; Beck, S; Penque, D ; Gonska, T; Seydewitz, HH; Mall, M; Amaral, MD ;
PUBLISHED: 2003, SOURCE: JOURNAL OF MEDICAL GENETICS, VOLUME: 40, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
44
TITLE: Unusually common cystic fibrosis mutation in Portugal encodes a misprocessed protein  Full Text
AUTHORS: Mendes, F ; Rosa, MR ; Dragomir, A; Farinha, CM ; Roomans, GM; Amaral, MD ; Penque, D ;
PUBLISHED: 2003, SOURCE: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, VOLUME: 311, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
45
TITLE: Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis
AUTHORS: Ramalho, AS ; Beck, S; Meyer, M; Penque, D ; Cutting, GR; Amaral, MD ;
PUBLISHED: 2002, SOURCE: AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, VOLUME: 27, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
47
TITLE: Cystic fibrosis patients with the 3272-26A > G splicing mutation have milder disease than F508del homozygotes: a large European study
AUTHORS: Amaral, MD ; Pacheco, P; Beck, S; Farinha, CM ; Penque, D ; Nogueira, P; Barreto, C; Lopes, B; Casals, T; Dapena, J; Gartner, S; Vasquez, C; Perez Frias, J; Olveira, C; Cabanas, R; Estivill, X; Tzetis, M; Kanavakis, E; Doudounakis, S; Dork, T; Tummler, B; Girodon Boulandet, E; Cazeneuve, C; Goossens, M; Blayau, M; Verlingue, C; Vieira, I; Ferec, C; Claustres, M; des Georges, M; Clavel, C; Birembaut, P; Hubert, D; Bienvenu, T; Adoun, M; Chomel, JC; De Boeck, K; Cuppens, H; Lavinha, J; ...More
PUBLISHED: 2001, SOURCE: JOURNAL OF MEDICAL GENETICS, VOLUME: 38, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
48
TITLE: Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells
AUTHORS: Penque, D ; Mendes, F ; Beck, S; Farinha, C ; Pacheco, P; Nogueira, P; Lavinha, J; Malho, R ; Amaral, MD ;
PUBLISHED: 2000, SOURCE: LABORATORY INVESTIGATION, VOLUME: 80, ISSUE: 6
INDEXED IN: Scopus WOS
IN MY: ORCID
49
TITLE: Cystic fibrosis patients with the 3272-26A -> G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane  Full Text
AUTHORS: Beck, S; Penque, D ; Garcia, S; Gomes, A ; Farinha, C ; Mata, L; Gulbenkian, S; Gil Ferreira, K; Duarte, A; Pacheco, P; Barreto, C; Lopes, B; Cavaco, J ; Lavinha, J; Amaral, MD ;
PUBLISHED: 1999, SOURCE: HUMAN MUTATION, VOLUME: 14, ISSUE: 2
INDEXED IN: WOS CrossRef: 1
50
TITLE: Cystic fibrosis patients with the 3272-26A→G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane  Full Text
AUTHORS: Beck, S; Penque, D ; Garcia, S; Gomes, A ; Farinha, C ; Mata, L; Gulbenkian, S; Gil Ferreira, K; Duarte, A; Pacheco, P; Barreto, C; Lopes, B; Cavaco, J ; Lavinha, J; Amaral, MD ;
PUBLISHED: 1999, SOURCE: Human Mutation, VOLUME: 14, ISSUE: 2
INDEXED IN: Scopus CrossRef: 50
IN MY: ORCID
Page 5 of 6. Total results: 53.